|
|
Volumn 44, Issue 10-11, 2011, Pages 930-932
|
|
Urinary calcium response to high dose vitamin D3 with calcium supplementation in patients with multiple sclerosis
|
|
Author keywords
25(OH)D; Calcium absorption; Calcium excretion; Calcium supplementation; Multiple sclerosis; Safety; Toxicity; Urinary calcium; Vitamin D supplementation
|
|
Indexed keywords
CALCIUM;
COLECALCIFEROL;
CREATININE;
ADULT;
ARTICLE;
CALCIUM EXCRETION;
CALCIUM METABOLISM;
CALCIUM URINE LEVEL;
CLINICAL ARTICLE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE URINE LEVEL;
DIET SUPPLEMENTATION;
DRUG DOSE ESCALATION;
DRUG DOSE TITRATION;
DRUG MEGADOSE;
DRUG SAFETY;
HUMAN;
KIDNEY CONCENTRATING CAPACITY;
MULTIPLE SCLEROSIS;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
VITAMIN D METABOLISM;
VITAMIN SUPPLEMENTATION;
ADULT;
CALCIUM;
CHOLECALCIFEROL;
CREATININE;
DIETARY SUPPLEMENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
MULTIPLE SCLEROSIS;
REGRESSION ANALYSIS;
|
|
EID: 79958782162
PISSN: 00099120
EISSN: 18732933
Source Type: Journal
DOI: 10.1016/j.clinbiochem.2011.04.017 Document Type: Article |
|
Times cited : (10)
|
|
References (12)
|
